OptiNose Performance
| OPTNDelisted Stock | USD 9.60 0.07 0.72% |
The company holds a Beta of 0.42, which implies possible diversification benefits within a given portfolio. As returns on the market increase, OptiNose's returns are expected to increase less than the market. However, during the bear market, the loss of holding OptiNose is expected to be smaller as well. OptiNose right now holds a risk of 0.0%. Please check OptiNose potential upside, as well as the relationship between the kurtosis and day typical price , to decide if OptiNose will be following its historical price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days OptiNose has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, OptiNose is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
OptiNose |
OptiNose Relative Risk vs. Return Landscape
If you would invest 960.00 in OptiNose on November 23, 2025 and sell it today you would earn a total of 0.00 from holding OptiNose or generate 0.0% return on investment over 90 days. OptiNose is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than OptiNose, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
OptiNose Target Price Odds to finish over Current Price
The tendency of OptiNose Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 9.60 | 90 days | 9.60 | about 18.17 |
Based on a normal probability distribution, the odds of OptiNose to move above the current price in 90 days from now is about 18.17 (This OptiNose probability density function shows the probability of OptiNose Stock to fall within a particular range of prices over 90 days) .
OptiNose Price Density |
| Price |
Predictive Modules for OptiNose
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as OptiNose. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of OptiNose's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
OptiNose Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. OptiNose is not an exception. The market had few large corrections towards the OptiNose's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold OptiNose, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of OptiNose within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.86 | |
β | Beta against Dow Jones | 0.42 | |
σ | Overall volatility | 1.76 | |
Ir | Information ratio | 0.12 |
OptiNose Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OptiNose for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OptiNose can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| OptiNose is not yet fully synchronised with the market data | |
| OptiNose has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 78.23 M. Net Loss for the year was (21.54 M) with profit before overhead, payroll, taxes, and interest of 74.11 M. | |
| OptiNose currently holds about 78.26 M in cash with (44.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94. | |
| Roughly 72.0% of the company shares are owned by institutional investors |
OptiNose Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OptiNose Stock often depends not only on the future outlook of the current and potential OptiNose's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OptiNose's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.2 M | |
| Cash And Short Term Investments | 84.5 M |
OptiNose Fundamentals Growth
OptiNose Stock prices reflect investors' perceptions of the future prospects and financial health of OptiNose, and OptiNose fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OptiNose Stock performance.
| Return On Equity | -10.5 | |||
| Return On Asset | -0.0997 | |||
| Profit Margin | (0.37) % | |||
| Operating Margin | (0.41) % | |||
| Current Valuation | 152.68 M | |||
| Shares Outstanding | 10.13 M | |||
| Price To Earning | (3.41) X | |||
| Price To Book | 24.26 X | |||
| Price To Sales | 1.19 X | |||
| Revenue | 78.23 M | |||
| EBITDA | (1.2 M) | |||
| Cash And Equivalents | 78.26 M | |||
| Cash Per Share | 0.94 X | |||
| Total Debt | 128.96 M | |||
| Book Value Per Share | (6.06) X | |||
| Cash Flow From Operations | (44.89 M) | |||
| Earnings Per Share | (2.17) X | |||
| Total Asset | 128.78 M | |||
| Retained Earnings | (741.92 M) | |||
| Current Asset | 83.03 M | |||
| Current Liabilities | 12.11 M | |||
About OptiNose Performance
By examining OptiNose's fundamental ratios, stakeholders can obtain critical insights into OptiNose's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that OptiNose is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Optinose operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 189 people.Things to note about OptiNose performance evaluation
Checking the ongoing alerts about OptiNose for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OptiNose help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OptiNose is not yet fully synchronised with the market data | |
| OptiNose has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 78.23 M. Net Loss for the year was (21.54 M) with profit before overhead, payroll, taxes, and interest of 74.11 M. | |
| OptiNose currently holds about 78.26 M in cash with (44.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94. | |
| Roughly 72.0% of the company shares are owned by institutional investors |
- Analyzing OptiNose's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OptiNose's stock is overvalued or undervalued compared to its peers.
- Examining OptiNose's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OptiNose's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OptiNose's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OptiNose's stock. These opinions can provide insight into OptiNose's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in OptiNose Stock
If you are still planning to invest in OptiNose check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OptiNose's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |